Norton Scientific Research Scam Fraud Detection

Norton intends to market simple-to-use products that can be used by technicians, rather than analysts, to be incorporated into any laboratories' own process control systems. By successfully integrating guided wave laser optics, microfluidics and robust data analysis software, researchers at Norton Scientific have invented a proprietary laser-based product that is now being marketed to laboratories and universities around the world.Targeting proteomics applications including crystallographers, the company is introducing this low-cost analytical system to researchers in biopharmaceutical and healthcare, advanced materials, food and beverage, bio-materials and in-water pollution monitoring.Norton intends to market simple-to-use products that can be used by technicians, rather than analysts, to be incorporated into any laboratories' own process control systems. Due to various applications of these materials, "macromolecule" covers the entire range of polymers and biopolymers − including proteins and peptides − that can be analysed using the intellectual property owned by NSI, such as contained in the revolutionary protein aggregation monitor (PAM).

Norton intends to market simple-to-use products that can be used by technicians, rather than analysts, to be incorporated into any laboratories' own process control systems. Norton Scientific " Main | Clinton Mccage By successfully integrating guided wave laser optics, microfluidics and robust data analysis software, researchers at Norton Scientific have invented a proprietary laser-based product that is now being marketed to laboratories and universities around the world.

http://business.wikinut.com/Norton-Scientific-By-Clinton-Mccage/2o17devz/ http://business.wikinut.com/Norton-Scientific-By-Clinton-Mccage/2o17devz/ Norton intends to market simple-to-use products that can be used by technicians, rather than analysts, to be incorporated into any laboratories' own process control systems. Norton Scientific » Main | Clinton Mccage By successfully integrating guided wave laser optics, microfluidics and robust data analysis software, researchers at Norton Scientific have invented a proprietary laser-based product that is now being marketed to laboratories and universities around the world. Targeting proteomics applications including crystallographers, the company is introducing this low-cost analytical system to researchers in biopharmaceutical and healthcare, advanced materials, food and beverage, bio-materials and in-water pollution monitoring. Norton intends to market simple-to-use products that can be used by technicians, rather than analysts, to be incorporated into any laboratories' own process control systems. Due to various applications of these materials, "macromolecule" covers the entire range of polymers and biopolymers − including proteins and peptides − that can be analysed using the intellectual property owned by NSI, such as contained in the revolutionary protein aggregation monitor (PAM).

Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.

XetraFrankfurt Intraday3 M6 M1 Y3 Y5 Y10 Y © Deutsche Börse Close Previous Day Price There is no push chart available at the moment. Open Xetra orderbook Add to watchlist Associated Instruments: Certificates, Leveraged, Bonds Frankfurt Realtime Bid / Ask 1.100 : 1.144 Volume 3,800 : 3,600 Spread abs/rel. 0.044 / 4.00% Change Prev. Day 0.022 / 2.00% Time 17/01/2012 15:30:09 Price Information XETRA* Frankfurt Last Price - 1.100 Date, Time - 17.01.2012 09:22 Change from Prev. Day - 0.000 / 0.00% Turnover in € - - Traded Units - - Price Fixings - 1 Bid/Ask - : - 1.100 : 1.144 Bid/Ask Volume in Units - : - 3,800 : 3,600 Bid/Ask Time - 17.01.2012 15:30:09 High - 1.100 Low - 1.100 52-Week High - 1.260 52-Week Low - 0.950 Close Previous Day - 1.100 Trading hours 09:00 - 17:30 08:00 - 20:00 * Xetra prices are 15 minutes delayed. Advertisement Fundamental Key Figures Dividend / Special dividend - / - Dividend Yield in % - Price Earnings Ratio - Earnings per Share (gross) in € - Earnings per Share (net) in € - Number of Shares - Market Capitalization in m. € - Freefloat Market Capitalisation in m. € - Major Master Data Transparency Level First Quotation Board Market Segment Open Market Trading Model Type - Country Canada Sector - Home exchange - Address Address - Phone - Fax - Internet - Contact - Technical Key Figures Historical Volatility 3 Month - Historical Volatility 250 Days - Correlation 30 Days - Correlation 52 Weeks - Beta 1 Year - Open Interest -

MARKHAM, ON, March 26, 2011 /24-7PressRelease/ -- Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.

Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.

Norton Scientific Scam Tumblr  - Norton Scientific - 4/11/2012 - This is a review of Broad and Wade's Betrayers of the Truth. The author uses a subtitle which is revealing: the loyalist responds to heresy not by seeing that something might be wrong, that there may be some merit to this sort of reassessment, but by defending the ideology. Zinder has managed to misread Broad and Wade in several places. There is sufficient misrepresentation to mean that he read the book very selectively. "The authors continually confound science with scientists. And the book not only fails to enlighten us on science but doesn't even begin to provide any insight on scientific method." (p. 94) "Thirty four cases of fraud over a 2,000 year period are documented in the book, a number roughly comparable to the number of lawyers who went to jail for Watergate. Despite this small number, the authors imply that scientific fraud is common

29March 2012 (Staffordshire) - A NN and Ewan Munro have not sat idle during the eight years in their home at this surprising semi. The couple has put in a new high efficiency gas combi boiler, rewired throughout, put in a new fitted kitchen with proper slate tiling laid there and in the hall, hung new doors, installed double glazing, put in a new bathroom with a Jacuzzi spa bath, created a loft room, planted a magnificent garden and created a driveway for several cars. The result is that the property at 108, Harrison Road, Norton, is a genuinely surprising and very appealing family home ready to be moved into tomorrow. My first impression of the house is that it is very light. Ewan knocked down a stud wall erected by the previous owner so the lounge and diner are now one room stretching more than 26 feet. With sliding patio doors at the back overlooking the garden and glass panelled doors from the hall and the kitchen and a generous bay window at the front as well, the room is flooded with light. It is also the perfect place for Ann to sit and watch her garden and its visitors. She says: "It is full of life and colour. Squirrels come and feed here and when it is in bloom it is like having the countryside in the back garden. We only know we have neighbours for four months of the year because when everything is in leaf it is just a riot of colour.'' The modern fitted kitchen has a range of Shaker style base and wall units, all the usual facilities plus space for a washing machine and tumble dryer and a double glazed door to the drive at the side and back garden. There is understairs storage in the hall and more on the landing. Upstairs the master bedroom at the back of the house has mirrored built in wardrobes, there is a second generous bedroom and the third can be used as either a study or as a single and the couple say there has been bunk beds in there too. Above them is a real surprise and delight feature because the loft has been c

http://business.wikinut.com/Norton-Scien tific-By-Clinton-Mccage/2o17devz/ Norton intends to market simple-to-use products that can be used by technicians, rather than analysts, to be incorporated into any laboratories’ own process control systems. Norton Scientific » Main | Clinton …

Norton intends to market simple-to-use products that can be used by technicians, rather than analysts, to be incorporated into any laboratories' own process control systems. Norton Scientific » Main | Clinton MccageBy successfully integrating guided wave laser optics, microfluidics and robust data analysis software, researchers at Norton Scientific have invented a proprietary laser-based product that is now being marketed to laboratories and universities around the world.Targeting proteomics applications including crystallographers, the company is introducing this low-cost analytical system to researchers in biopharmaceutical and healthcare, advanced materials, food and beverage, bio-materials and in-water pollution monitoring.Norton intends to market simple-to-use products that can be used by technicians, rather than analysts, to be incorporated into any laboratories' own process control systems. Due to various applications of these materials, "macromolecule" covers the entire range of polymers and biopolymers − including proteins and peptides − that can be analysed using the intellectual property owned by NSI, such as contained in the revolutionary protein aggregation monitor (PAM).

Norton Scientific today announced that the company has signed a deal with Advanced Scientific Technologies (AST), an independent sales rep company in Columbia, Maryland, to sell and support the Norton product line. "Tom Hill, the President of AST, is very excited about bringing the PAM and AstraGene products to the mid-Atlantic region of the United States," states Bryan Webb, President, Norton Scientific. The deal covers the District of Columbia, Delaware, Maryland, Virginia, South/Central Pennsylvania (including Pittsburgh) and South Jersey (south of Toms River). AST has a synergistic line of products including: Permeability & Solubility, pKa & log P, Dissolution, Microarrays, Scanner and Oligosynthesizer, 96/384 Plate-to-Plate transfers, Thermocyclers, Microfuges, Thermoshaker, Hybridization Oven, Electrophoresis and Electroblotting Systems, Power Supplies and Pipettes. Based in the Niagara Region of Canada, Norton was established in 2010 to take the knowledge and experience of the founders dating back 20+ years in the analysis of complex macromolecular & nano-particulate materials and design innovative measurement tools for use by bench scientists working in modern research facilities. Initial target markets for Norton are the important biochemical applications of protein aggregate screening and the kinetics of protein-protein interactions. Future developments will broaden this base to include applications in biopharmaceutical research, drug delivery, wound healing, advanced materials, food safety, brewing and viticulture, bio-materials and in-water pollution monitoring.

OverviewChartNewsPrice/Turnover HistoryMaster DataCompany Data XetraFrankfurt Intraday3 M6 M1 Y3 Y5 Y10 Y © Deutsche Börse Close Previous Day Price There is no push chart available at the moment. Open Xetra orderbook Add to watchlist Associated Instruments: Certificates, Leveraged, Bonds Frankfurt Realtime Bid / Ask 1.100 : 1.144 Volume 3,800 : 3,600 Spread abs/rel. 0.044 / 4.00% Change Prev. Day 0.022 / 2.00% Time 17/01/2012 15:30:09 Price Information XETRA* Frankfurt Last Price - 1.100 Date, Time - 17.01.2012 09:22 Change from Prev. Day - 0.000 / 0.00% Turnover in € - - Traded Units - - Price Fixings - 1 Bid/Ask - : - 1.100 : 1.144 Bid/Ask Volume in Units - : - 3,800 : 3,600 Bid/Ask Time - 17.01.2012 15:30:09 High - 1.100 Low - 1.100 52-Week High - 1.260 52-Week Low - 0.950 Close Previous Day - 1.100 Trading hours 09:00 - 17:30 08:00 - 20:00 * Xetra prices are 15 minutes delayed. Advertisement Fundamental Key Figures Dividend / Special dividend - / - Dividend Yield in % - Price Earnings Ratio - Earnings per Share (gross) in € - Earnings per Share (net) in € - Number of Shares - Market Capitalization in m. € - Freefloat Market Capitalisation in m. € - Major Master Data Transparency Level First Quotation Board Market Segment Open Market Trading Model Type - Country Canada Sector - Home exchange - Address Address - Phone - Fax - Internet - Contact - Technical Key Figures Historical Volatility 3 Month - Historical Volatility 250 Days - Correlation 30 Days - Correlation 52 Weeks - Beta 1 Year - Open Interest -

OverviewChartNewsPrice/Turnover HistoryMaster DataCompany Data XetraFrankfurt Intraday3 M6 M1 Y3 Y5 Y10 Y © Deutsche Börse Close Previous Day Price There is no push chart available at the moment. Open Xetra orderbook Add to watchlist Associated Instruments: Certificates, Leveraged, Bonds Frankfurt Realtime Bid / Ask 1.100 : 1.144 Volume 3,800 : 3,600 Spread abs/rel. 0.044 / 4.00% Change Prev. Day 0.022 / 2.00% Time 17/01/2012 15:30:09 Price Information XETRA* Frankfurt Last Price - 1.100 Date, Time - 17.01.2012 09:22 Change from Prev. Day - 0.000 / 0.00% Turnover in € - - Traded Units - - Price Fixings - 1 Bid/Ask - : - 1.100 : 1.144 Bid/Ask Volume in Units - : - 3,800 : 3,600 Bid/Ask Time - 17.01.2012 15:30:09 High - 1.100 Low - 1.100 52-Week High - 1.260 52-Week Low - 0.950 Close Previous Day - 1.100 Trading hours 09:00 - 17:30 08:00 - 20:00 * Xetra prices are 15 minutes delayed. Advertisement Fundamental Key Figures Dividend / Special dividend - / - Dividend Yield in % - Price Earnings Ratio - Earnings per Share (gross) in € - Earnings per Share (net) in € - Number of Shares - Market Capitalization in m. € - Freefloat Market Capitalisation in m. € - Major Master Data Transparency Level First Quotation Board Market Segment Open Market Trading Model Type - Country Canada Sector - Home exchange - Address Address - Phone - Fax - Internet - Contact - Technical Key Figures Historical Volatility 3 Month - Historical Volatility 250 Days - Correlation 30 Days - Correlation 52 Weeks - Beta 1 Year - Open Interest -

Their Accusation is based on an Opinion paper byRoberts and Tren published in Research and Reports in Tropical Medicine. Norton Scientific Scam | Friendfeed - Zimbio Fwd: Norton Scientific Scam | Tumblr In this piece Roger Bate, Donald Roberts and Richard Tren accuse the UN of "Scientific Fraud against DDT". Their Accusation is based on an Opinion paper byRoberts and Tren published in Research and Reports in Tropical Medicine. So let's look at their paper and see where the "Scientific Fraud" is. Norton Scientific Inc. (NSI) is a biotech company. The technology base and know-how involves the use of guided wave laser optics, microfluidics and robust data analysis software for the development of novel, low-cost, easy-to-use analytical separations systems for use in a variety of markets, including biopharmaceuticals, wound healing, food & beverage, bio-materials and environmental monitoring.

NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton saeo.net - Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance. Source: saeo.net #NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton #norton scientific reblog clintonmccage: NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance. Source: saeo.net #NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton #norton scientific reblog eddiemccrane: NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct

Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance, clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance. Class Agenda/Modules - Instructors Make a Difference Defining Clinical Research Fraud and Misconduct Evaluation of Case History R.E.S.E.A.R.C.H. TM Skills Program Advanced Auditing and Monitoring Skills for Prevention Case Development Typical Class Attendee - Sponsor Auditors Contract Research Organization Auditors Clinical Research Associates and Monitors Institutional Review Board Internal Auditors Food and Drug Administration Investigators Independent Consultant Auditors Compliance Auditors Experience Level - Advanced; CRC, CRA or Auditor position for two years, preferably with a four year medical or science degree Class Price - $1500 (10% Southeast Regional Discount and 10% multiple persons from the same organization discounts are available)

U.S. Senate Committee hears submissions on NASA's 2013 budget request & U.S. space program The U.S. Senate Committee on Commerce, Science, and Transportation has been hearing submissions regarding NASA's 2013 budget request and on the priorities, plans and progress of the U.S. space program. Witnesses appearing before the Committee on March 7 included Charles F Bolden Jr, NASA's Administrator, and Dr Neil deGrasse Tyson, an astrophysicist and well known commentator on space exploration. Bolden, who flew on four space shuttle missions after a career in the Marine Corps, was appointed to lead NASA in 2009 after being nominated by President Obama. Administrator Bolden outlined the space agency's achievements in 2011 and updated the Committee on the status of current missions. His statement outlined how the requested budget of $17.7 billion for 2013 would be allocated and concluded by stating: "NASA's FY 2013 budget request of $17.7 billion represents a substantial investment in a balanced program of science, exploration, technology and aeronautics research. Despite the constrained budget environment facing the Nation, this request supports a robust space program that keeps us on a path to achieving a truly audacious set of goals. NASA is working to send humans to an asteroid and ultimately to Mars, to observe the first galaxies form, and to expand the productivity of humanity's only permanently-crewed space station. We are making air travel safer and more efficient, learning to live and work in space, and developing the critical technologies to achieve these goals. The coming year will include the first commercial cargo flights to the ISS, a nuclear powered robot the size of a small car landing on the surface of Mars, and the launch of the Nation's next land observing satellite. We have spacecraft studying the Sun, circling Mercury, cruising to Pluto and investigating almost everything inbetween. In the face of very difficult times, the American p

The cancer society urged the federal government to: Ensure there is mandatory listing of unavailable drugs by drug manufacturer. Develop early warning systems to identify potential drug shortages. Put systems in place to prevent shortages from escalating. Work with other jurisdictions to investigate the root causes of the shortages and act to prevent them where possible. Canada's supply of injectable drugs such as painkillers, antibiotics and anesthetics became more precarious following a fire in the boiler room at Sandoz Canada's plant in Boucherville, Que. "Production has resumed in the portion of the plant that was not directly affected by the incident, which took place on March 4," the company said in a email to CBC News on Monday. "Our objective is to restore previous levels of supply as soon as possible, and we will make every effort to meet medical needs, while ensuring consistent high quality standards." Rationing supplies The company was unable to quantify how much more capacity it now has. Anthony Dale, vice-president of policy and public affairs at the Ontario Hospital Association in Toronto, called it "outrageous" that one company could have this kind of effect on drug supplies. Dale also called for a national strategy, noting hospitals are taking inventory of their supplies and trying to share and to compound or carefully mix drugs from raw ingredients under sterile conditions. Hospitals and drug purchasers have been holding daily conference calls to mitigate shortages. Doctors are carefully selecting patients who can swallow to give them oral forms of the medications, said Myrella Roy, executive director of the Canadian Society of Hospital Pharmacists in Ottawa. Last week, officials with Alberta Health Services asked doctors to conserve injectable medications. Cancer patients were asked to get oral anti-nausea medications instead of injections before chemotherapy treatment. In mid-February, Sandoz informed hospitals and other health-care client